Ann Oncol -- Table of Contents (May 2005, 16 [Supplement 1])

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Volume 16, 2005 Supplement 1 [Index by Author]

Recommendations

ESMO Minimum Clinical Recommendations

Guest Editors: ESMO Guidelines Task Force. This publication has been supported by an unrestricted educational grant from PharmaMar.

Find articles in this issue containing these words:
[Search ALL Issues]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Recommendations:

R. A. Stahel: ESMO Minimum Clinical Recommendations: assuring common standards of care
Ann Oncol 16: i5-i6; doi:10.1093/annonc/mdi801 [PDF]

B. C. Pestalozzi, E. Luporsi-Gely, L. M. Jost, and J. Bergh: ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer
Ann Oncol 16: i7-i9; doi:10.1093/annonc/mdi825 [PDF]

V. V. Kataja, M. Colleoni, and J. Bergh: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of locally recurrent or metastatic breast cancer (MBC)
Ann Oncol 16: i10-i12; doi:10.1093/annonc/mdi816 [PDF]

P. A. Vasey, J. Herrstedt, and S. Jelic: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of epithelial ovarian carcinoma
Ann Oncol 16: i13-i15; doi:10.1093/annonc/mdi823 [PDF]

E. J. D. Van Cutsem and V. V. Kataja: ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of colon cancer
Ann Oncol 16: i16-i17; doi:10.1093/annonc/mdi808 [PDF]

E. J. D. Van Cutsem, J. Oliveira, and V. V. Kataja: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of advanced colorectal cancer
Ann Oncol 16: i18-i19; doi:10.1093/annonc/mdi803 [PDF]

K. M. Tveit and V. V. Kataja: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of rectal cancer
Ann Oncol 16: i20-i21; doi:10.1093/annonc/mdi827 [PDF]

D. Cunningham, L. M. Jost, G. Purkalne, and J. Oliveira: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of gastric cancer
Ann Oncol 16: i22-i23; doi:10.1093/annonc/mdi812 [PDF]

R. Herrmann, L. M. Jost, and N. Pavlidis: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of pancreatic cancer
Ann Oncol 16: i24-i25; doi:10.1093/annonc/mdi824 [PDF]

M. Stahl, V. V. Kataja, and J. Oliveira: ESMO Minimal Clinical Recommendations for diagnosis, treatment and follow-up of esophageal cancer
Ann Oncol 16: i26-i27; doi:10.1093/annonc/mdi810 [PDF]

E. Felip, R. A. Stahel, and N. Pavlidis: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC)
Ann Oncol 16: i28-i29; doi:10.1093/annonc/mdi821 [PDF]

E. Felip, N. Pavlidis, and R. A. Stahel: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC)
Ann Oncol 16: i30-i31; doi:10.1093/annonc/mdi829 [PDF]

C. Manegold and R. A. Stahel: Minimum Clinical Recommendations for diagnosis, treatment and follow-up of malignant pleural mesothelioma
Ann Oncol 16: i32-i33; doi:10.1093/annonc/mdi835 [PDF]

V. V. Kataja and J. Bergh: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of prostate cancer
Ann Oncol 16: i34-i36; doi:10.1093/annonc/mdi826 [PDF]

R. A. Huddart and G. Purkalne: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of mixed or non-seminomatous germ cell tumors (NSGCT)
Ann Oncol 16: i37-i39; doi:10.1093/annonc/mdi817 [PDF]

R. A. Huddart and V. V. Kataja: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of testicular seminoma
Ann Oncol 16: i40-i42; doi:10.1093/annonc/mdi832 [PDF]

V. V. Kataja and N. Pavlidis: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of invasive bladder cancer
Ann Oncol 16: i43-i44; doi:10.1093/annonc/mdi815 [PDF]

J.-L. Harrouseau, R. Greil, and O. Kloke: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of multiple myeloma
Ann Oncol 16: i45-i47; doi:10.1093/annonc/mdi818 [PDF]

M. F. Fey, R. Greil, and L. M. Jost: ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of acute myeloblastic leukemia (AML) in adult patients
Ann Oncol 16: i48-i49; doi:10.1093/annonc/mdi802 [PDF]

M. Hallek, R. A. Stahel, and R. Greil: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of chronic lymphocytic leukemia
Ann Oncol 16: i50-i51; doi:10.1093/annonc/mdi806 [PDF]

B. Simonsson, O. Kloke, and R. A. Stahel: ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of chronic myelogenous leukemia (CML)
Ann Oncol 16: i52-i53; doi:10.1093/annonc/mdi807 [PDF]

L. M. Jost and R. A. Stahel: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of Hodgkin's disease
Ann Oncol 16: i54-i55; doi:10.1093/annonc/mdi814 [PDF]

W. Hiddemann, M. Dreyling, and R. A. Stahel: Minimum Clinical Recommendations for diagnosis, treatment and follow-up of newly diagnosed follicular lymphoma
Ann Oncol 16: i56-i57; doi:10.1093/annonc/mdi819 [PDF]

L. M. Jost, O. Kloke, and R. A. Stahel: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of newly diagnosed large cell non-Hodgkin's lymphoma
Ann Oncol 16: i58-i59; doi:10.1093/annonc/mdi820 [PDF]

L. M. Jost and R. A. Stahel: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of relapsed large cell non-Hodgkin's lymphoma
Ann Oncol 16: i60-i61; doi:10.1093/annonc/mdi828 [PDF]

X. Pivot, V.V. Kataja, and S. Jelic: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of squamous cell carcinoma of the head and neck (SCCHN)
Ann Oncol 16: i62-i63; doi:10.1093/annonc/mdi831 [PDF]

R. Stupp, N. Pavlidis, and S. Jelic: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of malignant glioma
Ann Oncol 16: i64-i65; doi:10.1093/annonc/mdi834 [PDF]

L. M. Jost, S. Jelic, and G. Purkalne: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cutaneous malignant melanoma
Ann Oncol 16: i66-i68; doi:10.1093/annonc/mdi809 [PDF]

S. Leyvraz and S. Jelic: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of soft tissue sarcomas
Ann Oncol 16: i69-i70; doi:10.1093/annonc/mdi830 [PDF]

G. Saeter, O. Kloke, and S. Jelic: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of osteosarcoma
Ann Oncol 16: i71-i72; doi:10.1093/annonc/mdi822 [PDF]

G. Saeter, J. Oliveira, and J. Bergh: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of Ewing's sarcoma of bone
Ann Oncol 16: i73-i74; doi:10.1093/annonc/mdi811 [PDF]

E. Briasoulis, C. Tolis, J. Bergh, and N. Pavlidis: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cancers of unknown primary site (CUP)
Ann Oncol 16: i75-i76; doi:10.1093/annonc/mdi804 [PDF]

J. Herrstedt, M. S. Aapro, F. Roila, and V. V. Kataja: ESMO Minimum Clinical Recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV)
Ann Oncol 16: i77-i79; doi:10.1093/annonc/mdi805 [PDF]

R. Greil and L. M. Jost: ESMO recommendations for the application of hematopoietic growth factors
Ann Oncol 16: i80-i82; doi:10.1093/annonc/mdi813 [PDF]

L. M. Jost: ESMO Minimum Clinical Recommendations for the management of cancer pain
Ann Oncol 16: i83-i85; doi:10.1093/annonc/mdi833 [PDF]

Annals of Oncology

Recommendations: